MedTrace Logo

Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose

NCT00507013 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2008-04-24

No results posted yet for this study

Summary

The QuickClose study is a prospective, non-randomized study, to evaluate the safety and efficacy of the QuickClose device using two different dose types of heat exposure.

Patients undergoing a diagnostic angiogram procedure will be treated with the QuickClose device. Two groups of 20 patients each, will be enrolled consecutively, Group A will complete enrollment before enrollment into Group B begins. Patients will be monitored until 30 days after the procedure

Conditions

  • Hemostasis,Surgical

Interventions

DEVICE

QuickClose device

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • CardioDex

    lead INDUSTRY

Principal Investigators

  • Amit Segev, MD · The Chaim Sheba Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Completion
2007-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507013 on ClinicalTrials.gov